CardiaLen's Angel - IV Round

CardiaLen raised a round of funding on February 01, 2013. Investors include St. Louis Arch Angels.

CardiaLen develops and commercializes pain-free cardioversion therapy, with a primary focus on atrial fibrillation (AF). The company is developing implantable low-energy (low voltage) pain-free atrial…

Articles about CardiaLen's Angel - IV Round: